All studies
RecruitingTherapeutic confirmatory (Phase III)Interventional

ESONIA - The evaluation of efficacy and safety of Nebivolol in the treatment of arterial hypertension in adolescents.

High blood pressure, also known as hypertension, means blood pushes against the walls of blood vessels with too much force. While often seen in adults, it can also affect young people and cause long-term health issues if left untreated. This trial investigates a tablet called nebivolol (under the brand name Nebilenin) to see how safe and effective it is for adolescents. Nebivolol belongs to a common group of blood pressure medicines known as beta-blockers, which help blood vessels relax and widen. Researchers will follow participants over several months to track their blood pressure using measurements taken at the clinic and at home. They will also closely check for any unwanted side effects. The goal is to see if nebivolol brings blood pressure back into a healthy range for teenagers, providing doctors with better evidence-based treatment options for younger patients.

At a glance

Status
Recruiting
Phase
Therapeutic confirmatory (Phase III)
Sponsor
Medical University Of Warsaw
Enrolment target
150
Start
02 Dec 2024

What is this study about?

Blood pressure is the measure of how hard your blood pushes against the sides of your arteries as it moves around your body. When this pressure stays too high for a long time, it can put extra strain on the heart, kidneys, and blood vessels. Even though we usually think of high blood pressure as a condition that affects older adults, it can also develop in teenagers and young people.

Treating high blood pressure early helps protect long-term health and prevents problems later in life. However, many medicines used today were originally tested mainly on adults. Doctors need clear evidence to know which treatments are both safe and effective for younger bodies. This clinical trial, named ESONIA, aims to fill that gap by studying a medicine called nebivolol specifically in adolescents.

Nebivolol is a type of medicine known as a beta-blocker. It works by slowing down the heart rate and helping blood vessels relax and open up, which allows blood to flow more easily and lowers pressure. By taking daily tablets, participants will help researchers understand whether nebivolol can safely bring high blood pressure down to normal levels in teenagers over a 38-week period.

Key takeaways

  • The ESONIA trial tests if nebivolol tablets can safely lower high blood pressure in teenagers.
  • Nebivolol works by relaxing blood vessels and easing the strain on the heart.
  • Participation lasts about 38 weeks and includes clinic visits and home blood pressure tracking.
  • Taking part is completely voluntary, and you can stop at any time without affecting your usual care.
  • Both parents and teenagers must agree before joining the study.

Who may be eligible?

This study is designed for teenagers and adolescents who have been diagnosed with high blood pressure (arterial hypertension). Both boys and girls can take part. Because the trial focuses on young people, participants will generally need to be within the typical adolescent age range, though the clinic team will confirm the exact age limits.

To join, a young person must have high blood pressure that needs medical treatment, as confirmed by doctor checks. Teenagers who have other complex health conditions, severe heart problems, or known allergies to beta-blockers may not be able to join, as their safety is the top priority.

Because participants are under adult age, a parent or legal guardian will need to give permission, and the teenager will also be asked to agree (give assent) before taking part in any study tests.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you a teenager or adolescent?
  2. Have you been diagnosed with high blood pressure (hypertension)?
  3. Are you able to swallow a tablet once a day?
  4. Are you willing to attend regular clinic check-ups over several months?
  5. Does your parent or legal guardian support you taking part?
Answer every question to see your result.

What does participation involve?

Taking part in this study lasts for up to 38 weeks (about 9 months). During this time, participants will be asked to take a nebivolol tablet by mouth once a day, as instructed by the study doctor.

Participants will attend regular hospital or clinic appointments so doctors can check their health. These visits will include standard blood pressure checks using an arm cuff, as well as general physical check-ups. At certain points, participants will also wear a small, portable blood pressure monitor for 24 hours (known as an ambulatory blood pressure monitor) to see how their pressure changes during normal daily activities and while sleeping.

Young people and their families will also be asked to take blood pressure readings at home during specific weeks and keep a simple record. The study team will closely monitor for any side effects and will be available to answer questions throughout the entire trial.

Potential risks and benefits

A potential benefit of joining this study is that the medicine may help lower your blood pressure into a healthier range, and you will receive regular, detailed health checks from specialist doctors. However, like all medicines, nebivolol can cause side effects. Common side effects of beta-blockers can include feeling tired, dizzy, having cold hands or feet, or a slower heart rate. There is also a chance the medicine may not work as well as hoped. Taking part is completely voluntary; you and your family can choose to leave the study at any time without giving a reason, and your normal NHS care will not be affected.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    Poland

Common questions

What is nebivolol?

Nebivolol is a prescription tablet called a beta-blocker. It helps widen blood vessels and gently slows the heart rate to lower high blood pressure.

Will taking part hurt?

No. Most checks involve painless blood pressure cuffs placed on your arm. Wearing the 24-hour monitor can feel slightly tight when it inflates, but it is not harmful.

Can I carry on with school and sports?

In most cases, yes. The study team will let you know if any intense physical activities need to be adjusted while your blood pressure is being monitored.

What if I get side effects?

You should tell the study team right away. They can adjust your dose, offer advice, or stop the medicine if it is causing problems.

Do I have to pay to take part?

No, clinical trials do not charge for study medicines or tests, and travel costs to clinic visits are often reimbursed.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "ESONIA - The evaluation of efficacy and safety of Nebivolol …" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.